by Jordana Choucair | Jun 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first treatment for alopecia treatment that restores hair growth. The agency said that two trials showed that Eli Lilly & Co.’s Olumiant helped roughly 40 percent of the 1,2000 trial participants achieve...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
An amendment to the Senate’s latest FDA user fee proposal calls on infant formula manufacturers to notify the agency within five business days of a disruption to their supply chain, an attempt to better guard against future formula shortages. The amendment...
by Jordana Choucair | Jun 14, 2022 | Opioid/Substance Use Disorders
A new report found that fatal drug overdoses rose nearly 15 percent in Kentucky last year, surpassing 2,000 deaths and setting a record death toll in the state. According to the report, released by the Kentucky Justice and Public Safety Cabinet and the Office of Drug...
by Jordana Choucair | Jun 14, 2022 | Payers
eHealth released a survey indicating that 13 percent of Medicare Advantage (MA) enrollees had a claim or pre-authorization request denied. Of those, 43 percent said their plan told them the claim was excluded from coverage. Another 15 percent said coverage was denied...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) released briefing documents indicating that Moderna’s and Pfizer-BioNTech’s COVID-19 vaccines are both effective and safe for children 5 years old and younger. The FDA documents found that the Pfizer-BioNTech vaccine was...
Recent Comments